Sep 2026· Digital Discovery· 0 citations· 32 references
Medicine
TL;DR
Under inactive-enriched training, PLEC-based support vector regression (SVR) models achieved robust and strong VS performance, highlighting the critical role of learning the vast diversity of inactive molecules better during model training in developing predictive target-specific ML SFs for TRPM8 VS.
Abstract
The Transient Receptor Potential Melastatin 8 (TRPM8) ion channel is an emerging therapeutic target implicated in pain, inflammation and other disorders. While structure-based virtual screening (VS) is widely used in drug discovery, the effectiveness of generic and target-specific machine-learning (ML) scoring functions (SFs) for ion channels such as TRPM8 remains to be investigated. We established the first comprehensive structure-based VS benchmark for TRPM8. This evaluates classical docking SFs, generic ML SFs and target-specific ML models retrospectively across multiple TRPM8 protein conformations and docking protocols. The evaluation revealed that generic ML rescoring at most provided modest and conformation-dependent improvements over classical docking on this target. Target-specific ML models based only on protein–ligand interaction fingerprints improved early enrichment on test sets when regression algorithms were employed. However, performance remained sensitive to protein conformation choice and chemical dissimilarity. Systematic evaluation of feature representations showed that combining structure-derived interaction features with ligand-based descriptors enhanced enrichment under selected docking tool-protein conformation combinations. Critically, presenting the learning algorithm with many more negative training instances, via inactive-enriched training, strongly reduced false positives. This also resulted in markedly improved generalization to chemically dissimilar test sets for structure-based models. By contrast, ligand-only QSAR models collapsed under the same class-imbalanced regime. Under inactive-enriched training, PLEC-based support vector regression (SVR) models achieved robust and strong VS performance, highlighting the critical role of learning the vast diversity of inactive molecules better during model training in developing predictive target-specific ML SFs for TRPM8 VS.
Results demonstrate that approaches incorporating machine learning and structure-based computational analysis can be useful for discovering and prioritizing potential IRAK4 inhibitor candidates.
H. Na, Juwon Park, Jiwon Choi· Current Issues in Molecular...· 0 citations
The convergence of docking, dynamics, and free-energy results prioritized PM2, PM3, and PM4 as promising MAP3K8 hit candidates, which require further experimental validation and lead optimization.
M. Islam, A. Iqbal, M. A. Ali et al.· Molecular diversity· 0 citations
A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.
Luca Chiesa, G. Bret, Severine Schneider et al.· Journal of Chemical Informat...· 0 citations
These findings identified CMNPD11687 as a promising marine-derived scaffold for PIM-1 inhibition and demonstrated the value of combining ML-driven screening with molecular simulation to accelerate early-stage anticancer drug discovery.
Bishal Budha, Arjun Acharya, Madan Khanal et al.· Research in Pharmaceutical S...· 0 citations
The serotonin transporter (SERT) plays a pivotal role in inflammatory responses and is a central therapeutic target for depression. Consequently, identifying potent SERT inhibitors remains a high priority in early-stage drug discovery. In this study, we evaluated twelve regression models, among which LightGBM, Random F...
This work demonstrates that integrating docking-derived pharmacophores with conformational ensemble-based machine learning provides an effective approach for discovering novel inhibitors against underexplored kinase targets.
G. Shakhatreh, M. Taha, S. Daoud· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.